Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

THC Biomed Intl Ltd C.THC

Alternate Symbol(s):  THCBF

THC Biomed Intl Ltd. is a Canada-based cannabis producer. The Company’s principal business is the production and sale of cannabis through THC BioMed Ltd., which is a small batch Licensed Producer as regulated by the Cannabis Act which regulates the production, distribution, and possession of cannabis for both medical and adult recreational access in Canada. The Company’s biological assets consist of cannabis plants (mother plants and clones for growth); resin; oil; harvested marijuana flowers prior to completion of the drying, grading and testing processes; and edible concentrate. The Company operates in a single reportable segment being the cultivation and sale of cannabis. Its subsidiaries include THC BioMed Ltd., Clone Shipper Ltd., THC BioMed Victoria Falls Ltd., THC2GO Dispensaries Ltd. (THC2GO), and THC BioMed Lesotho Ltd. (THC Lesotho). Clone Shipper Ltd. owns all rights to the Clone Shipper product used to transport live plants.


CSE:THC - Post by User

Post by RamboOO7on Jun 24, 2022 7:41am
153 Views
Post# 34779541

We should see increase flow in this financial quarter

We should see increase flow in this financial quarterAs well as a roughly $600,000.00 profit from selling the building. The Company hereby confirms the receipt of $2,626,350.61 as payment of consideration in connection with the sale of property disclosed in its Form 10 Notice of Proposed Significant Transaction (the Transaction) filed with the Canadian Securities Exchange on April 11, 2022. Approximately $890,000 plus per diems have been used to pay out the remaining mortgage on the property and approximately $99,777 has been paid for commissions. The remaining proceeds will be used to reduce the Companys liabilities and general working capital.
<< Previous
Bullboard Posts
Next >>